Cadre Holdings, Inc. (CDRE) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
24/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseCDRE / S&P -6.76% / 15.20% |
WinCDRE / S&P 19.74% / 15.00% |
LoseCDRE / S&P -13.83% / 50.40% |
| 2026-Q11/3 |
LoseCDRE / S&P -24.69% / -4.33% |
WinCDRE / S&P 13.54% / 11.30% |
LoseCDRE / S&P -10.53% / 27.70% |
| 2025-Q42/3 |
WinCDRE / S&P 12.11% / 2.65% |
LoseCDRE / S&P 7.53% / 9.00% |
WinCDRE / S&P 14.44% / 13.40% |
| 2025-Q33/3 |
WinCDRE / S&P 14.96% / 8.12% |
WinCDRE / S&P 19.94% / 4.61% |
WinCDRE / S&P 34.94% / 13.45% |
| 2025-Q21/3 |
LoseCDRE / S&P 7.91% / 10.94% |
WinCDRE / S&P 7.66% / 4.83% |
LoseCDRE / S&P -8.74% / 10.63% |
| 2025-Q11/3 |
LoseCDRE / S&P -8.11% / -4.27% |
WinCDRE / S&P 10.06% / 4.98% |
LoseCDRE / S&P -5.94% / 10.57% |
| 2024-Q41/3 |
LoseCDRE / S&P -14.67% / 2.41% |
WinCDRE / S&P 17.62% / 5.25% |
LoseCDRE / S&P -11.76% / 6.15% |
| 2024-Q32/3 |
WinCDRE / S&P 13.36% / 5.89% |
WinCDRE / S&P 7.18% / 5.89% |
LoseCDRE / S&P -12.63% / 6.11% |
| 2024-Q22/3 |
LoseCDRE / S&P -7.05% / 4.28% |
WinCDRE / S&P 13.64% / 5.38% |
WinCDRE / S&P 30.38% / 5.12% |
| 2024-Q12/3 |
LoseCDRE / S&P 10.35% / 10.56% |
WinCDRE / S&P 9.34% / 5.71% |
WinCDRE / S&P 62.90% / 5.59% |
| 2023-Q42/3 |
WinCDRE / S&P 23.76% / 11.69% |
LoseCDRE / S&P 5.39% / 6.81% |
WinCDRE / S&P 684.62% / 7.78% |
| 2023-Q33/3 |
WinCDRE / S&P 22.66% / -3.27% |
WinCDRE / S&P 10.02% / 7.52% |
WinCDRE / S&P 955.56% / -5.03% |
| 2023-Q21/3 |
LoseCDRE / S&P 1.60% / 8.74% |
WinCDRE / S&P 10.17% / 9.50% |
LoseCDRE / S&P -443.48% / -8.57% |
| 2023-Q10/3 |
LoseCDRE / S&P 7.32% / 7.50% |
LoseCDRE / S&P 10.45% / 10.77% |
LoseCDRE / S&P -720.00% / -15.69% |
| 2022-Q40/3 |
LoseCDRE / S&P -16.07% / 7.56% |
LoseCDRE / S&P 7.15% / 11.88% |
LoseCDRE / S&P -71.11% / -17.99% |
| 2022-Q31/3 |
WinCDRE / S&P 22.75% / -4.88% |
LoseCDRE / S&P 1.47% / 13.47% |
LoseCDRE / S&P -89.89% / -1.41% |
| 2022-Q20/3 |
LoseCDRE / S&P -19.66% / -16.10% |
LoseCDRE / S&P -3.11% / 13.71% |
LoseCDRE / S&P -117.56% / 11.04% |
| 2022-Q11/3 |
WinCDRE / S&P -3.03% / -4.60% |
LoseCDRE / S&P CDRE unavailable / 15.97% |
LoseCDRE / S&P CDRE unavailable / 42.23% |
| 2021-Q40/3 |
LoseCDRE / S&P CDRE unavailable / 11.03% |
LoseCDRE / S&P CDRE unavailable / 15.00% |
LoseCDRE / S&P CDRE unavailable / 96.40% |
| 2021-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 0.58% |
LoseCDRE / S&P CDRE unavailable / 10.77% |
LoseCDRE / S&P CDRE unavailable / 69.42% |
| 2021-Q20/3 |
LoseCDRE / S&P CDRE unavailable / 8.55% |
LoseCDRE / S&P CDRE unavailable / 6.58% |
LoseCDRE / S&P CDRE unavailable / 51.81% |
| 2021-Q10/3 |
LoseCDRE / S&P CDRE unavailable / 6.17% |
LoseCDRE / S&P CDRE unavailable / -1.06% |
LoseCDRE / S&P CDRE unavailable / 7.39% |
| 2020-Q40/3 |
LoseCDRE / S&P CDRE unavailable / 12.15% |
LoseCDRE / S&P CDRE unavailable / -3.72% |
LoseCDRE / S&P CDRE unavailable / -33.42% |
| 2020-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 8.93% |
LoseCDRE / S&P CDRE unavailable / -2.04% |
LoseCDRE / S&P CDRE unavailable / -27.10% |
| 2020-Q20/3 |
LoseCDRE / S&P CDRE unavailable / 20.54% |
LoseCDRE / S&P CDRE unavailable / -0.46% |
LoseCDRE / S&P CDRE unavailable / -27.11% |
| 2020-Q10/3 |
LoseCDRE / S&P CDRE unavailable / -19.60% |
LoseCDRE / S&P CDRE unavailable / 3.47% |
LoseCDRE / S&P CDRE unavailable / -14.75% |
| 2019-Q40/3 |
LoseCDRE / S&P CDRE unavailable / 9.07% |
LoseCDRE / S&P CDRE unavailable / 5.36% |
LoseCDRE / S&P CDRE unavailable / 2.99% |
| 2019-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 1.70% |
LoseCDRE / S&P CDRE unavailable / 5.02% |
LoseCDRE / S&P CDRE unavailable / 0.21% |
| 2019-Q20/3 |
LoseCDRE / S&P CDRE unavailable / 4.30% |
LoseCDRE / S&P CDRE unavailable / 6.64% |
LoseCDRE / S&P CDRE unavailable / 8.65% |
| 2019-Q10/3 |
LoseCDRE / S&P CDRE unavailable / 13.65% |
LoseCDRE / S&P CDRE unavailable / 8.12% |
LoseCDRE / S&P CDRE unavailable / 14.29% |
| 2018-Q40/3 |
LoseCDRE / S&P CDRE unavailable / -13.52% |
LoseCDRE / S&P CDRE unavailable / 9.05% |
LoseCDRE / S&P CDRE unavailable / 18.23% |
| 2018-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 7.71% |
LoseCDRE / S&P CDRE unavailable / 10.21% |
LoseCDRE / S&P CDRE unavailable / 19.06% |
| 2018-Q20/3 |
LoseCDRE / S&P CDRE unavailable / 3.43% |
LoseCDRE / S&P CDRE unavailable / 9.03% |
LoseCDRE / S&P CDRE unavailable / 14.46% |
| 2018-Q10/3 |
LoseCDRE / S&P CDRE unavailable / -0.76% |
LoseCDRE / S&P CDRE unavailable / 7.68% |
LoseCDRE / S&P CDRE unavailable / 12.46% |
| 2017-Q40/3 |
LoseCDRE / S&P CDRE unavailable / 6.64% |
LoseCDRE / S&P CDRE unavailable / 7.03% |
LoseCDRE / S&P CDRE unavailable / 13.82% |
| 2017-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 4.48% |
LoseCDRE / S&P CDRE unavailable / 5.68% |
LoseCDRE / S&P CDRE unavailable / 17.57% |
| 2017-Q20/3 |
LoseCDRE / S&P CDRE unavailable / 3.09% |
LoseCDRE / S&P CDRE unavailable / 4.83% |
LoseCDRE / S&P CDRE unavailable / 17.74% |
| 2017-Q10/3 |
LoseCDRE / S&P CDRE unavailable / 6.07% |
LoseCDRE / S&P CDRE unavailable / 3.67% |
LoseCDRE / S&P CDRE unavailable / 13.32% |
| 2016-Q40/3 |
LoseCDRE / S&P CDRE unavailable / 3.82% |
LoseCDRE / S&P CDRE unavailable / 2.09% |
LoseCDRE / S&P CDRE unavailable / 7.05% |
| 2016-Q30/3 |
LoseCDRE / S&P CDRE unavailable / 3.85% |
LoseCDRE / S&P CDRE unavailable / 0.20% |
LoseCDRE / S&P CDRE unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CDRE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 2.10% | 20.78% |
| Annualized return | 2.10% | 20.78% |
5Y · 2021-11-04 to 2026-08-27
| Metric | CDRE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 116.09% | 83.14% |
| Annualized return | 16.66% | 12.86% |
10Y · 2021-11-04 to 2026-08-27
| Metric | CDRE total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 116.09% | 319.30% |
| Annualized return | 8.01% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |